Study maps Atlantic salmon immune response to T. dicentrarchi
Bottom line
A new study in Animals offers one of the clearest looks yet at how Atlantic salmon respond immunologically to Tenacibaculum dicentrarchi, a key cause of tenacibaculosis in Chilean aquaculture. Using both primary head kidney macrophages exposed to live bacteria and samples from naturally infected fish, the researchers found an early, sustained pro-inflammatory response, with upregulation of markers including il1b, il8, inos, tnfa, il12, and arginase. The work adds mechanistic detail to a disease that has become a major production concern in Chile, where tenacibaculosis has ranked behind piscirickettsiosis as a leading infectious cause of mortality in Atlantic salmon. (was.org)
Why it matters: For veterinary professionals in aquaculture, the study helps fill a notable knowledge gap around host response to T. dicentrarchi, at a time when Chilean regulators and producers are paying closer attention to tenacibaculosis surveillance, case definition, and co-infections, especially with SRS. Better understanding of the early M1-type inflammatory response and the skin-associated nature of infection could inform diagnostics, timing of intervention, biomarker development, and future vaccine or immunomodulatory strategies in a disease area where control still leans heavily on antibiotics and no salmonid vaccine is currently available. (was.org)
What to watch: Watch for follow-on work linking these immune markers to field diagnostics, co-infection management, and vaccine development against Tenacibaculum in salmonids. (pucv.cl)
Key facts
- Study type
- In vitro and in vivo immunology study in Atlantic salmon
- Journal
- Animals
- Pathogen
- Tenacibaculum dicentrarchi
- Disease
- Tenacibaculosis
- Model
- Primary head kidney macrophages and naturally infected fish
- Main finding
- Early, sustained pro-inflammatory response consistent with M1-type macrophage activation
- Markers upregulated
- il1b, il8, inos, tnfa, il12, and arginase
- Regional context
- Chilean Atlantic salmon aquaculture
- Industry context
- Tenacibaculosis ranked behind piscirickettsiosis as a leading infectious cause of mortality in Atlantic salmon
A new Animals paper adds important immunology data to one of Chilean salmon farming’s most persistent bacterial disease challenges: tenacibaculosis caused by Tenacibaculum dicentrarchi. The study used both in vitro stimulation of Atlantic salmon head kidney macrophages and in vivo sampling from naturally infected fish, and found a predominantly early pro-inflammatory response, consistent with M1-type macrophage activation. (was.org)
That matters because tenacibaculosis has become a much bigger issue in Chile over the past several years. Chile’s fisheries and aquaculture authority, Sernapesca, reported that in Atlantic salmon, tenacibaculosis accounted for 37.9% of infectious mortality in 2023, second only to piscirickettsiosis. In the 2025 annual sanitary report, piscirickettsiosis remained the top infectious cause of mortality in Atlantic salmon, followed again by tenacibaculosis. (sernapesca.cl)
The broader research backdrop also helps explain why this paper is timely. Prior work from Chilean groups has highlighted concern about Tenacibaculum coinfection with Piscirickettsia salmonis, and separate INCAR research has pointed to skin mucus as a critical first-line barrier, showing that T. dicentrarchi strains are attracted to Atlantic salmon mucus regardless of whether fish are healthy or infected. Together, those findings have pushed attention toward host defense mechanisms at the skin surface and toward the immunopathology of mixed infections. (pucv.cl)
According to related conference reporting from the same research line, the investigators used a Chilean T. dicentrarchi isolate to stimulate primary head kidney macrophages from smoltified Atlantic salmon and assessed responses with qPCR, immunofluorescence, and ELISA. In vitro, inflammatory genes including il1b, il8, and inos peaked around 12 hours post-stimulation, while TNFα and IL-10 protein expression was also detected. In samples from field cases, the team saw increased expression of arginase, tnfa, il1b, and il12, supporting the conclusion that infection triggers a strong early inflammatory program. (was.org)
There doesn’t appear to be a broad wave of outside commentary on this specific paper yet, but the industry and regulatory context points to why the findings are likely to resonate. Sernapesca updated its tenacibaculosis definition and surveillance framework this month, including broader recognition of multiple Tenacibaculum agents and the challenge of distinguishing pure tenacibaculosis from co-occurring disease, particularly SRS. The agency said those changes are intended to improve epidemiologic understanding and will be followed by further review of diagnostic test performance. (sernapesca.cl)
Why it matters: For aquatic animal health teams, this study gives a more concrete picture of the host pathways engaged during T. dicentrarchi infection, which could support more targeted monitoring and intervention. If the early inflammatory signature proves reproducible in field settings, it may help refine biomarkers for earlier detection or severity assessment. It also reinforces the importance of barrier health, lesion surveillance, and differential diagnosis in fish with external disease, especially where coinfections may blur attribution. In practical terms, that’s relevant in a setting where no salmonid vaccine is currently available for tenacibaculosis and control has relied largely on antimicrobials such as florfenicol and oxytetracycline. (was.org)
The paper may also help shape future R&D priorities. A clearer map of macrophage polarization and cytokine signaling could be useful for vaccine design, adjuvant selection, functional feed development, or other immunomodulatory approaches. That’s especially pertinent as the disease burden remains high and as regulators sharpen surveillance definitions to better separate Tenacibaculum-driven mortality from overlapping syndromes. (sernapesca.cl)
What to watch: The next step is whether these immune markers can be translated into field-usable tools, and whether future studies connect them to outcomes such as lesion progression, coinfection risk, treatment response, or protection in vaccine trials. (pucv.cl)